dihexa also known as pnb 0408 Dihexa | | 1401708-83-5 |

For inflammatory bowel disease research, both peptides show promise with complementary mechanisms

Third-party COA We require a Certificate of Analysis issued by an independent lab - not the vendor - and confirm the batch number matches the product currently being sold

This efficiency not only benefits the healthcare team but also enhances the patient experience by allowing for quicker initiation of therapy

Unlike synthetic pharmaceuticals, peptides work with the bodys natural processes, making them an effective and well-tolerated option for many health concerns

doi: 10.3390/ph18020185

Dihexa (CAS 1401708-83-5, also labeled PNB-0408) has never been studied in a placebo-controlled human trial, so there is no clinically established onset window for it at all